Profound Medical Corp (PRN.TO)
10.61
+0.06
(+0.57%)
CAD |
TSX |
Nov 22, 16:00
Profound Medical Enterprise Value: 232.58M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 232.58M |
| November 21, 2024 | 231.10M |
| November 20, 2024 | 234.80M |
| November 19, 2024 | 238.75M |
| November 18, 2024 | 243.93M |
| November 15, 2024 | 242.70M |
| November 14, 2024 | 249.60M |
| November 13, 2024 | 248.12M |
| November 12, 2024 | 250.09M |
| November 11, 2024 | 252.56M |
| November 08, 2024 | 266.37M |
| November 07, 2024 | 275.50M |
| November 06, 2024 | 247.13M |
| November 05, 2024 | 240.72M |
| November 04, 2024 | 251.08M |
| November 01, 2024 | 224.94M |
| October 31, 2024 | 221.24M |
| October 30, 2024 | 227.16M |
| October 29, 2024 | 224.69M |
| October 28, 2024 | 228.39M |
| October 25, 2024 | 219.76M |
| October 24, 2024 | 217.05M |
| October 23, 2024 | 217.79M |
| October 22, 2024 | 224.94M |
| October 21, 2024 | 225.43M |
| Date | Value |
|---|---|
| October 18, 2024 | 236.04M |
| October 17, 2024 | 234.56M |
| October 16, 2024 | 231.10M |
| October 15, 2024 | 231.10M |
| October 11, 2024 | 228.64M |
| October 10, 2024 | 224.45M |
| October 09, 2024 | 227.40M |
| October 08, 2024 | 230.61M |
| October 07, 2024 | 226.67M |
| October 04, 2024 | 234.31M |
| October 03, 2024 | 236.53M |
| October 02, 2024 | 242.70M |
| October 01, 2024 | 235.79M |
| September 30, 2024 | 236.28M |
| September 27, 2024 | 224.20M |
| September 26, 2024 | 221.02M |
| September 25, 2024 | 208.53M |
| September 24, 2024 | 210.00M |
| September 23, 2024 | 210.73M |
| September 20, 2024 | 217.34M |
| September 19, 2024 | 222.24M |
| September 18, 2024 | 213.67M |
| September 17, 2024 | 217.34M |
| September 16, 2024 | 220.28M |
| September 13, 2024 | 220.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
27.21M
Minimum
Oct 26 2022
613.05M
Maximum
Feb 05 2021
253.25M
Average
245.47M
Median
Enterprise Value Benchmarks
| Biocure Technology Inc | 0.4866M |
| Core One Labs Inc | -- |
| Restart Life Sciences Corp | 1.234M |
| Nanosphere Health Sciences Inc | 0.2679M |
| Lobe Sciences Ltd | 5.616M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.78M |
| Revenue (Quarterly) | 3.864M |
| Total Expenses (Quarterly) | 16.13M |
| EPS Diluted (Quarterly) | -0.5185 |
| Gross Profit Margin (Quarterly) | 63.77% |
| Profit Margin (Quarterly) | -330.6% |
| Earnings Yield | -17.19% |
| Normalized Earnings Yield | -17.19 |